SCHEDULE: Vanguard Discloses 7.49% Stake in Insulet Corp

Vanguard Capital Management has reported a beneficial ownership of 7.49% in Insulet Corp's common stock as of March 31, 2026.

Summary

• Vanguard Capital Management, along with its affiliates, now beneficially owns 5,277,842 shares of Insulet Corp common stock.
• This holding represents 7.49% of the class of securities.
• Vanguard Capital Management has sole voting power over 698,568 shares and sole dispositive power over 5,277,842 shares.
• The filing indicates that Vanguard funds and other managed accounts have the right to receive or direct the receipt of dividends and sale proceeds for these securities, with no single other person holding more than a 5% interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by a large investment manager and does not contain company-specific performance or strategic information.

Positives

• Vanguard's significant stake suggests confidence in Insulet Corp's long-term prospects.
• The reporting of sole dispositive power indicates clear control over the investment decisions for these shares.

Negatives

• The filing does not contain any negative financial or operational information about Insulet Corp itself, as it is a disclosure of beneficial ownership by an investment manager.

Risks

• The filing does not explicitly mention any risks related to Insulet Corp's business operations or financial health. The primary risk is inherent in any investment, which is market volatility and the potential for share price decline.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Insulet Corp. Vanguard's future actions regarding its stake are not specified.

Industry Context

StockSavvy.ai notes that significant holdings by major institutional investors like Vanguard often signal stability and potential growth, but this filing is purely a disclosure of ownership and does not provide operational insights into Insulet Corp's performance relative to industry peers.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can be viewed positively for stability, but does not directly impact current operations or immediate share price without further context.
• Management and Employees: The filing does not directly affect management or employees, but a stable, significant shareholder base can contribute to long-term strategic planning.
• Creditors: The filing does not directly impact creditors.

Next Steps

• Vanguard will continue to manage its investment in Insulet Corp, potentially adjusting its stake based on market conditions and investment strategy.
• Insulet Corp will continue its business operations as disclosed in its other SEC filings.

Key Dates

Keywords

Insulet Corp, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Management, Shareholder